Schedule 13G ownership disclosure

Corvus Pharmaceuticals Inc

Common Stock, $0.0001 par value per share · CUSIP: 221015100

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Richard A. Miller

    Shares: 6,085,922.00 · Class: 7.8%

  • Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985

    Shares: 1,188,103.00 · Class: 1.6%

  • Sandra J. Horning

    Shares: 1,188,103.00 · Class: 1.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-26-015263
Form type
SCHEDULE 13G/A
Filer
Corvus Pharmaceuticals, Inc.
CIK
CIK 1626971
Filed
Feb 13, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub